AKEBIA THERAPEUTICS, INC. Incentive from Lessor
AKEBIA THERAPEUTICS, INC. (AKBA) had Incentive from Lessor of $3.29 million as of 2018-04-30, per its 10-K filed 2019-03-26.
Discontinued › Notes › Leases
us-gaap:IncentiveFromLessor · last filed 2019-03-26
- 2018-04-30: Incentive from Lessor $3.29M.
- 2018-03-31: Incentive from Lessor $2.17M.
- 2017-12-31: Incentive from Lessor $2.17M.
- 2017-09-30: Incentive from Lessor $2.17M.
| Period end | Incentive from Lessor |
|---|---|
| 2018-04-30 | $3.29M 10-K · filed 2019-03-26 |
| 2018-03-31 | $2.17M 10-Q · filed 2018-08-08 |
| 2017-12-31 | $2.17M 10-K · filed 2018-03-12 |
| 2017-09-30 | $2.17M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $2.17M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $2.17M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $2.17M 10-K · filed 2017-03-06 |
| 2016-09-30 | $2.17M 10-Q · filed 2016-11-09 |
| 2013-12-31 | $31.00K 10-Q · filed 2016-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |